FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029385336> ?p ?o ?g. }

• W2029385336 endingPage "19" @default.
• W2029385336 startingPage "9" @default.
• W2029385336 abstract "The pharmacotherapy for the treatment of pain is an active area of investigation. There are effective drugs to treat this problem, but there is also a need to find alternative treatments free of undesirable side effects. In the present work the capacity of a series of flavonoids to bind to the μ opioid receptor was evaluated. The most active compound, 3,3-dibromoflavanone (31), a synthetic flavonoid, presented a significant inhibition of the binding of the selective μ opioid ligand [3H]DAMGO, with a Ki of 0.846 ± 0.263 μM. Flavanone 31 was further synthesized using a simple and cheap procedure with good yield. Its in vivo effects in mice, after acute treatments, were studied using antinociceptive and behavioral assays. It showed no sedative, anxiolytic, motor incoordination effects or inhibition of the gastrointestinal transit in mice at the doses tested. It evidenced antinociceptive activity on the acetic acid-induced nociception, hot plate and formalin tests (at 10 mg/kg and 30 mg/kg). The results showed that the 5-HT2 receptor and the adrenoceptors seem unlikely to be involved in its antinociceptive effects. Naltrexone, a nonselective opioid receptors antagonist, totally blocked compound 31 antinociceptive effects on the hot plate test, but naltrindole (δ opioid antagonist) and nor-binaltorphimine (κ opioid antagonist) did not. These findings demonstrated that 3,3-dibromoflavanone (31), at doses that did not interfere with the motor performance, exerted clear dose dependent antinociception when assessed in the chemical and thermal models of nociception in mice and it seems that its action is related to the activation of the μ opioid receptor." @default.
• W2029385336 created "2016-06-24" @default.
• W2029385336 creator A5020251125 @default.
• W2029385336 creator A5047537187 @default.
• W2029385336 creator A5082352446 @default.
• W2029385336 creator A5084966105 @default.
• W2029385336 date "2013-09-01" @default.
• W2029385336 modified "2023-09-25" @default.
• W2029385336 title "In vitro binding affinities of a series of flavonoids for μ-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice" @default.
• W2029385336 cites W1563143030 @default.
• W2029385336 cites W1785185999 @default.
• W2029385336 cites W1970960534 @default.
• W2029385336 cites W1977211513 @default.
• W2029385336 cites W1986062274 @default.
• W2029385336 cites W1986988181 @default.
• W2029385336 cites W1987249287 @default.
• W2029385336 cites W1988468898 @default.
• W2029385336 cites W1989451305 @default.
• W2029385336 cites W1991829271 @default.
• W2029385336 cites W1998957314 @default.
• W2029385336 cites W2001005561 @default.
• W2029385336 cites W2003338094 @default.
• W2029385336 cites W2003454699 @default.
• W2029385336 cites W2004160613 @default.
• W2029385336 cites W2004843753 @default.
• W2029385336 cites W2008939320 @default.
• W2029385336 cites W2009345240 @default.
• W2029385336 cites W2011683631 @default.
• W2029385336 cites W2023292449 @default.
• W2029385336 cites W2027007649 @default.
• W2029385336 cites W2032058764 @default.
• W2029385336 cites W2032577690 @default.
• W2029385336 cites W2033488756 @default.
• W2029385336 cites W2037909257 @default.
• W2029385336 cites W2038207028 @default.
• W2029385336 cites W2045506303 @default.
• W2029385336 cites W2048695976 @default.
• W2029385336 cites W2053557807 @default.
• W2029385336 cites W2054751165 @default.
• W2029385336 cites W2057250059 @default.
• W2029385336 cites W2066334362 @default.
• W2029385336 cites W2068281182 @default.
• W2029385336 cites W2071289233 @default.
• W2029385336 cites W2072901945 @default.
• W2029385336 cites W2073844986 @default.
• W2029385336 cites W2074192779 @default.
• W2029385336 cites W2083014566 @default.
• W2029385336 cites W2084032809 @default.
• W2029385336 cites W2088795816 @default.
• W2029385336 cites W2093460741 @default.
• W2029385336 cites W2125299541 @default.
• W2029385336 cites W2127812895 @default.
• W2029385336 cites W2129304351 @default.
• W2029385336 cites W2141764590 @default.
• W2029385336 cites W2146599011 @default.
• W2029385336 cites W2149023391 @default.
• W2029385336 cites W2157626286 @default.
• W2029385336 cites W2468875624 @default.
• W2029385336 cites W4293247451 @default.
• W2029385336 cites W44878263 @default.
• W2029385336 doi "https://doi.org/10.1016/j.neuropharm.2013.04.020" @default.
• W2029385336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23624290" @default.
• W2029385336 hasPublicationYear "2013" @default.
• W2029385336 type Work @default.
• W2029385336 sameAs 2029385336 @default.
• W2029385336 citedByCount "39" @default.
• W2029385336 countsByYear W20293853362014 @default.
• W2029385336 countsByYear W20293853362015 @default.
• W2029385336 countsByYear W20293853362016 @default.
• W2029385336 countsByYear W20293853362017 @default.
• W2029385336 countsByYear W20293853362018 @default.
• W2029385336 countsByYear W20293853362019 @default.
• W2029385336 countsByYear W20293853362020 @default.
• W2029385336 countsByYear W20293853362021 @default.
• W2029385336 countsByYear W20293853362022 @default.
• W2029385336 countsByYear W20293853362023 @default.
• W2029385336 crossrefType "journal-article" @default.
• W2029385336 hasAuthorship W2029385336A5020251125 @default.
• W2029385336 hasAuthorship W2029385336A5047537187 @default.
• W2029385336 hasAuthorship W2029385336A5082352446 @default.
• W2029385336 hasAuthorship W2029385336A5084966105 @default.
• W2029385336 hasConcept C15490471 @default.
• W2029385336 hasConcept C170493617 @default.
• W2029385336 hasConcept C185592680 @default.
• W2029385336 hasConcept C2776885963 @default.
• W2029385336 hasConcept C2777953665 @default.
• W2029385336 hasConcept C2777972943 @default.
• W2029385336 hasConcept C2779886867 @default.
• W2029385336 hasConcept C2781063702 @default.
• W2029385336 hasConcept C55493867 @default.
• W2029385336 hasConcept C71924100 @default.
• W2029385336 hasConcept C98274493 @default.
• W2029385336 hasConceptScore W2029385336C15490471 @default.
• W2029385336 hasConceptScore W2029385336C170493617 @default.
• W2029385336 hasConceptScore W2029385336C185592680 @default.
• W2029385336 hasConceptScore W2029385336C2776885963 @default.
• W2029385336 hasConceptScore W2029385336C2777953665 @default.
• W2029385336 hasConceptScore W2029385336C2777972943 @default.

• next